Creative Financial Designs Inc. ADV acquired a new position in Tempus AI, Inc. (NASDAQ:TEM – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 743 shares of the company’s stock, valued at approximately $47,000.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. ARK Investment Management LLC grew its holdings in Tempus AI by 35.9% during the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock valued at $361,867,000 after purchasing an additional 1,981,755 shares during the period. Vanguard Group Inc. raised its position in shares of Tempus AI by 6,247.5% in the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock worth $289,204,000 after buying an additional 5,900,668 shares in the last quarter. Nikko Asset Management Americas Inc. raised its position in shares of Tempus AI by 31.5% in the first quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company’s stock worth $205,401,000 after buying an additional 1,021,460 shares in the last quarter. CloudAlpha Capital Management Limited Hong Kong purchased a new stake in shares of Tempus AI in the first quarter worth $34,119,000. Finally, Massachusetts Financial Services Co. MA raised its position in shares of Tempus AI by 92.6% in the first quarter. Massachusetts Financial Services Co. MA now owns 578,890 shares of the company’s stock worth $27,926,000 after buying an additional 278,311 shares in the last quarter. 24.22% of the stock is owned by hedge funds and other institutional investors.
Tempus AI Price Performance
Shares of NASDAQ TEM opened at $88.71 on Tuesday. Tempus AI, Inc. has a twelve month low of $31.36 and a twelve month high of $104.32. The firm has a market cap of $15.41 billion, a P/E ratio of -74.55 and a beta of 4.86. The company has a 50 day moving average of $85.68 and a 200 day moving average of $70.21. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58.
Analyst Upgrades and Downgrades
Several research firms recently issued reports on TEM. Cowen cut Tempus AI from a “buy” rating to a “hold” rating in a research note on Tuesday, October 21st. TD Cowen cut Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 target price on the stock. in a research note on Tuesday, October 21st. Weiss Ratings reissued a “sell (d-)” rating on shares of Tempus AI in a research note on Wednesday, October 8th. Piper Sandler lifted their price objective on Tempus AI from $70.00 to $105.00 and gave the company a “neutral” rating in a research report on Wednesday, October 22nd. Finally, BTIG Research lifted their price objective on Tempus AI from $85.00 to $96.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Seven equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Tempus AI currently has an average rating of “Hold” and an average target price of $79.38.
Check Out Our Latest Stock Analysis on Tempus AI
Insider Activity
In related news, CEO Eric P. Lefkofsky sold 332,500 shares of the company’s stock in a transaction on Tuesday, October 28th. The shares were sold at an average price of $89.11, for a total value of $29,629,075.00. Following the completion of the transaction, the chief executive officer owned 9,074,532 shares of the company’s stock, valued at approximately $808,631,546.52. This represents a 3.53% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Erik Phelps sold 3,664 shares of the business’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $273,517.60. Following the completion of the sale, the executive vice president owned 94,115 shares in the company, valued at approximately $7,025,684.75. The trade was a 3.75% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 1,099,912 shares of company stock worth $87,247,931. Company insiders own 26.27% of the company’s stock.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading
- Five stocks we like better than Tempus AI
- 3 Monster Growth Stocks to Buy Now
- Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
- Why Are These Companies Considered Blue Chips?
- The Best Local Butchers for Thanksgiving [2025 Survey]
- What Investors Need to Know to Beat the Market
- $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM – Free Report).
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.
